Briefly, obesity and insulin resistance are key drivers, the latter triggering an increased flux of circulating free fatty acids (FFAs) from insulin-resistant peripheral adipose tissue to the liver [19,20,21]. The gene discussed is INS; the disease is Insulin resistance.